Skip to content

13F-HR filed by HealthCor Management, L.P.

HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 37 holding rows worth $3,072,518,000.

Accession
0001343781-18-000002
Filed
2018-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 37 entries on the cover page, a total value of $3,072,518,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,072,521,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Merck & Co.,Inc.58933Y105COM3,900,000$219,453,000thousands by filing date
BIOVERATIV INC09075E100COM3,750,000$202,200,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock1,525,000$184,022,000thousands by filing date
CELGENE CORP151020104COM1,725,000$180,021,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW1,100,000$175,461,000thousands by filing date
Medtronic PlcG5960L103COM1,950,000$157,463,000thousands by filing date
ALLERGAN PLCG0177J108SHS825,000$134,954,000thousands by filing date
INCYTE CORP COM45337C102Stock1,350,000$127,859,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock2,800,000$127,820,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock325,000$122,187,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM1,525,000$118,325,000thousands by filing date
BAXTER INTL INC071813109COM1,725,000$111,504,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM725,000$108,649,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock1,450,000$84,216,000thousands by filing date
CVS Health Corporation126650100COM1,125,000$81,563,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM221,470$80,823,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock783,380$76,693,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,309,960$72,886,000thousands by filing date
AbbVie,Inc.00287Y109COM749,410$72,475,000thousands by filing date
Elevance Health, Inc.036752103COM316,180$71,144,000thousands by filing date
UnitedHealth Group Inc91324P102COM315,000$69,445,000thousands by filing date
PEDIATRIX MEDICAL GROUP INC58502B106COM1,261,620$67,421,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM973,840$66,221,000thousands by filing date
HUMANA INC COM444859102Stock263,440$65,352,000thousands by filing date
LIVANOVA PLCG5509L101SHS622,997$49,790,000thousands by filing date
ZOETIS INC CL A98978V103Stock645,100$46,473,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock2,956,351$44,818,000thousands by filing date
Johnson & Johnson478160104COM194,610$27,191,000thousands by filing date
Stryker Corporation863667101COM166,280$25,747,000thousands by filing date
Bristol-Myers Squibb Company110122108COM404,670$24,798,000thousands by filing date
CORINDUS VASCULAR ROBOTICS I218730109COM19,981,655$20,181,000thousands by filing date
Abbott Laboratories002824100COM244,950$13,979,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock100,000$12,067,000thousands by filing datecall
Danaher Corporation235851102COM124,660$11,571,000thousands by filing date
Boston Scientific Corporation101137107COM367,832$9,119,000thousands by filing date
Mallinckrodt PlcG5785G107SHS284,400$6,416,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock101,000$2,214,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001343781-18-000002this filing2018-02-14acceptance time not in the bulk data set